SG11201406199TA - Methods for treating cancer using pi3k inhibitor and mek inhibitor - Google Patents
Methods for treating cancer using pi3k inhibitor and mek inhibitorInfo
- Publication number
- SG11201406199TA SG11201406199TA SG11201406199TA SG11201406199TA SG11201406199TA SG 11201406199T A SG11201406199T A SG 11201406199TA SG 11201406199T A SG11201406199T A SG 11201406199TA SG 11201406199T A SG11201406199T A SG 11201406199TA SG 11201406199T A SG11201406199T A SG 11201406199TA
- Authority
- SG
- Singapore
- Prior art keywords
- inhibitor
- methods
- treating cancer
- pi3k
- mek
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261621252P | 2012-04-06 | 2012-04-06 | |
| FR1351158 | 2013-02-12 | ||
| US201361771457P | 2013-03-01 | 2013-03-01 | |
| PCT/US2013/035231 WO2013152165A1 (en) | 2012-04-06 | 2013-04-04 | Methods for treating cancer using pi3k inhibitor and mek inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201406199TA true SG11201406199TA (en) | 2014-10-30 |
Family
ID=49301040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201406199TA SG11201406199TA (en) | 2012-04-06 | 2013-04-04 | Methods for treating cancer using pi3k inhibitor and mek inhibitor |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20150031882A1 (en) |
| EP (1) | EP2854854A1 (en) |
| JP (1) | JP2015515476A (en) |
| KR (1) | KR20150003786A (en) |
| CN (1) | CN104334192A (en) |
| AU (1) | AU2013243429A1 (en) |
| CA (1) | CA2869152A1 (en) |
| CL (1) | CL2014002668A1 (en) |
| CO (1) | CO7121349A2 (en) |
| CR (1) | CR20140480A (en) |
| DO (1) | DOP2014000221A (en) |
| EA (1) | EA201491836A1 (en) |
| MX (1) | MX2014012001A (en) |
| PE (1) | PE20142020A1 (en) |
| PH (1) | PH12014502219A1 (en) |
| SG (1) | SG11201406199TA (en) |
| TN (1) | TN2014000418A1 (en) |
| WO (1) | WO2013152165A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6727127B2 (en) * | 2013-12-20 | 2020-07-29 | バイオメッド バレー ディスカバリーズ，インコーポレイティド | Cancer treatment using a combination of PI3K/AKT signaling pathway inhibitors and ERK inhibitors |
| WO2017065277A1 (en) * | 2015-10-14 | 2017-04-20 | 日東紡績株式会社 | Method for determining drug-sensitive human cell lines by analysis method in which measurement of activity of two types of protein kinase is used |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7956191B2 (en) | 2004-10-20 | 2011-06-07 | Merck Serono Sa | 3-arylamino pyridine derivatives |
| CA2623768C (en) | 2005-10-07 | 2016-04-12 | Exelixis, Inc. | N-(3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| NZ594628A (en) * | 2005-10-07 | 2013-04-26 | Exelixis Inc | PYRIDOPYRIMIDINONE INHIBITORS OF PI3Ka |
| BR112012008483A2 (en) * | 2009-10-12 | 2019-09-24 | Hoffmann La Roche | combinations of a pi3k inhibitor and a mex inhibitor |
| AR084216A1 (en) * | 2010-12-09 | 2013-05-02 | Sanofi Sa | COMPOSITIONS AND METHODS TO TREAT CANCER USING A PI3K INHIBITOR AND MEK INHIBITOR, KIT |
-
2013
- 2013-04-04 AU AU2013243429A patent/AU2013243429A1/en not_active Abandoned
- 2013-04-04 EA EA201491836A patent/EA201491836A1/en unknown
- 2013-04-04 SG SG11201406199TA patent/SG11201406199TA/en unknown
- 2013-04-04 KR KR20147030877A patent/KR20150003786A/en not_active Application Discontinuation
- 2013-04-04 CA CA2869152A patent/CA2869152A1/en not_active Abandoned
- 2013-04-04 EP EP13717123.7A patent/EP2854854A1/en not_active Withdrawn
- 2013-04-04 PE PE2014001533A patent/PE20142020A1/en not_active Application Discontinuation
- 2013-04-04 CN CN201380029317.1A patent/CN104334192A/en active Pending
- 2013-04-04 WO PCT/US2013/035231 patent/WO2013152165A1/en active Application Filing
- 2013-04-04 MX MX2014012001A patent/MX2014012001A/en unknown
- 2013-04-04 JP JP2015504716A patent/JP2015515476A/en active Pending
-
2014
- 2014-10-01 PH PH12014502219A patent/PH12014502219A1/en unknown
- 2014-10-01 DO DO2014000221A patent/DOP2014000221A/en unknown
- 2014-10-02 US US14/504,970 patent/US20150031882A1/en not_active Abandoned
- 2014-10-02 TN TN2014000418A patent/TN2014000418A1/en unknown
- 2014-10-03 CL CL2014002668A patent/CL2014002668A1/en unknown
- 2014-10-16 CR CR20140480A patent/CR20140480A/en unknown
- 2014-10-29 CO CO14239743A patent/CO7121349A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CR20140480A (en) | 2014-11-17 |
| AU2013243429A1 (en) | 2014-10-23 |
| MX2014012001A (en) | 2015-05-11 |
| CL2014002668A1 (en) | 2015-01-16 |
| US20150031882A1 (en) | 2015-01-29 |
| KR20150003786A (en) | 2015-01-09 |
| JP2015515476A (en) | 2015-05-28 |
| CO7121349A2 (en) | 2014-11-20 |
| PH12014502219A1 (en) | 2015-01-12 |
| CN104334192A (en) | 2015-02-04 |
| TN2014000418A1 (en) | 2016-03-30 |
| EA201491836A1 (en) | 2015-02-27 |
| DOP2014000221A (en) | 2014-12-15 |
| PE20142020A1 (en) | 2014-12-24 |
| EP2854854A1 (en) | 2015-04-08 |
| WO2013152165A1 (en) | 2013-10-10 |
| CA2869152A1 (en) | 2013-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288181A (en) | Methods of treating cancer | |
| HRP20171474T1 (en) | Triazolopyrazines as brd4 inhibitors for use in the treatment of cancer | |
| HK1209798A1 (en) | Compositions and methods for treating cancer | |
| IL237791A0 (en) | Method of treating cancer | |
| EP2836482A4 (en) | Compositions and methods for treating cancer | |
| EP2890720A4 (en) | Compositions and methods for treating cancer | |
| IL227429A0 (en) | Compositions and methods for treating cancer | |
| EP2755482A4 (en) | Compositions and methods for treating cancer | |
| SG11201503893RA (en) | Method of treating cancer | |
| EP2895206A4 (en) | Method of treating cancer | |
| HK1216854A1 (en) | Compositions and methods for treating cancer | |
| IL229231A0 (en) | Compositions and methods for treating cancer | |
| EP2825693A4 (en) | Methods and materials for treating cancer | |
| SG11201406199TA (en) | Methods for treating cancer using pi3k inhibitor and mek inhibitor | |
| HK1207561A1 (en) | Compositions and methods for treating hepatocellular cancer | |
| IL234913A0 (en) | Methods for treating cancer using pi3k inhibitor and mek inhibitor | |
| EP2841102A4 (en) | Methods and compositions for treating cancer | |
| EP2822593A4 (en) | Compositions and methods for treating cancer | |
| EP2709623A4 (en) | Medicaments and methods for treating cancer |